Detalhe da pesquisa
1.
Pathogenic Germline Variants in 10,389 Adult Cancers.
Cell
; 173(2): 355-370.e14, 2018 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29625052
2.
CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.
Cell
; 168(5): 801-816.e13, 2017 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28215704
3.
Epigenetic regulation during cancer transitions across 11 tumour types.
Nature
; 623(7986): 432-441, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914932
4.
Transfer of Cell-Surface Antigens by Scavenger Receptor CD36 Promotes Thymic Regulatory T Cell Receptor Repertoire Development and Allo-tolerance.
Immunity
; 48(5): 923-936.e4, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29752065
5.
Flotetuzumab and other T-cell immunotherapies upregulate MHC class II expression on acute myeloid leukemia cells.
Blood
; 141(14): 1718-1723, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36563336
6.
S100A9 upregulated by IFNGR signaling blockade functions as a novel GVHD suppressor without compromising GVL in mice.
Blood
; 141(8): 945-950, 2023 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477272
7.
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers.
N Engl J Med
; 384(10): 924-935, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33704937
8.
Proteomic and phosphoproteomic landscapes of acute myeloid leukemia.
Blood
; 140(13): 1533-1548, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35895896
9.
The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission: a retrospective analysis.
Blood
; 140(20): 2101-2112, 2022 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35877996
10.
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.
Blood
; 139(8): 1177-1183, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34797911
11.
Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes.
Proc Natl Acad Sci U S A
; 118(49)2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34845035
12.
Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
J Virol
; 96(7): e0005722, 2022 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35319225
13.
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.
Blood
; 137(6): 751-762, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929488
14.
Liposomal phytohemagglutinin: In vivo T-cell activator as a novel pan-cancer immunotherapy.
J Cell Mol Med
; 26(3): 940-944, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35014164
15.
CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas.
Blood
; 136(20): 2308-2318, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32614951
16.
Transfer of Cell-Surface Antigens by Scavenger Receptor CD36 Promotes Thymic Regulatory T Cell Receptor Repertoire Development and Allo-tolerance.
Immunity
; 48(6): 1271, 2018 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29924978
17.
BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a study.
Cancer
; 127(8): 1246-1259, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33270904
18.
Immune Escape of Relapsed AML Cells after Allogeneic Transplantation.
N Engl J Med
; 379(24): 2330-2341, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30380364
19.
Mutation Clearance after Transplantation for Myelodysplastic Syndrome.
N Engl J Med
; 379(11): 1028-1041, 2018 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30207916
20.
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.
Nature
; 518(7540): 552-555, 2015 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25487151